Craig Marc Luetjens
Research Subjects
Craig Marc Luetjens has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Ernesto Macías
Department of Medicine and Nutrition, University of Guanajuato, León, Guanajuato, Mexico
1 shared publication Alessandra Coppo
Bracco Imaging Spa Milano Italy
1 shared publicationAnn Baker
Covance Laboratories Inc., Madison, USA
1 shared publicationAntje Fuchs
Covance Preclinical Services GmbH, Kesselfeld 29, 48163 Munster, Germany
1 shared publication- Christopher Payne
Departments of Obstetrics & Gynecology and Cell & Developmental Biology, Oregon Health Sciences University, and Oregon Regional Primate Research Center, Beaverton, OR 97006, USA
1 shared publication Clemens Günther
Bayer AG Berlin Germany
1 shared publication
Latest Publications
- 16 April 2025
- Published by Wiley in Birth Defects Research
- Vol. 117 (4) , e2470
Evaluation of Gadolinium‐Based Contrast Agents in Juvenile Non‐Human Primates Including Behavioral Evaluations Such as Learning and Memory
Background: The US Food and Drug Administration (FDA) requested the four Gadolinium‐Based Contrast Agents (GBCA) New Drug Application (NDA) holders to investigate the effects of gadolinium (Gd) retention on fetal and neonatal development in mice and juvenile non‐human primates (NHP) as well as the effects of repeated GBCA administrations on behavioral, neurological, and histopathological endpoints.Methods: Two linear (gadodiamide and gadobenate dimeglumine) and one macrocyclic (gadobutrol) GBCA, intended to be representative of linear non‐ionic, linear ionic, and macrocyclic GBCAs, were investigated in a juvenile toxicity study in the cynomolgus monkey. Clinical observations, body weight, food consumption, clinical chemistry, full histopathology, and behavioral/neurological parameters including learning and memory were assessed. Additionally, Gd was quantified in the brain and other selected organs/tissues. A total of 84 juvenile animals (n = 12/group) were intravenously dosed every 4 weeks from postnatal day 28 for a total of 8 administrations over 29 weeks. Evaluation at the end of dosing, or after a recovery phase, was conducted to assess the reversibility of any observed effects. Necropsy was performed on Day 198 of the dosing phase for four animals/group and Day 365 of the recovery phase for the remaining eight animals/group.Results: No GBCA‐related adverse effects were observed in juvenile cynomolgus monkeys either at the end of the dosing or recovery periods. The no‐observed‐effect‐levels (NOEL) for gadobutrol and gadodiamide administration were 0.9 mmol/kg and, for gadobenate dimeglumine, 0.3 mmol/kg (due to a non‐adverse difference in learning during the recovery phase in the high dose group). The no‐observed‐adverse‐effect‐level (NOAEL) for all GBCAs was established as at least 0.9 mmol/kg.Conclusions: Gd levels observed in brain tissue of cynomolgus monkey after juvenile exposure to multiples of equivalent clinical doses of all GBCAs tested did not correlate with any adverse morphological or functional findings. This study showed no evidence that exposure to GBCA during development presents a potential risk for long‐term effects such as behavioral, neurological, or histopathological findings in the brain, and/or impaired learning or memory.
- 16 April 2025
- Published by Wiley in Birth Defects Research
- Vol. 117 (4) , e2470
Evaluation of Gadolinium‐Based Contrast Agents in Juvenile Non‐Human Primates Including Behavioral Evaluations Such as Learning and Memory
Background: The US Food and Drug Administration (FDA) requested the four Gadolinium‐Based Contrast Agents (GBCA) New Drug Application (NDA) holders to investigate the effects of gadolinium (Gd) retention on fetal and neonatal development in mice and juvenile non‐human primates (NHP) as well as the effects of repeated GBCA administrations on behavioral, neurological, and histopathological endpoints.Methods: Two linear (gadodiamide and gadobenate dimeglumine) and one macrocyclic (gadobutrol) GBCA, intended to be representative of linear non‐ionic, linear ionic, and macrocyclic GBCAs, were investigated in a juvenile toxicity study in the cynomolgus monkey. Clinical observations, body weight, food consumption, clinical chemistry, full histopathology, and behavioral/neurological parameters including learning and memory were assessed. Additionally, Gd was quantified in the brain and other selected organs/tissues. A total of 84 juvenile animals (n = 12/group) were intravenously dosed every 4 weeks from postnatal day 28 for a total of 8 administrations over 29 weeks. Evaluation at the end of dosing, or after a recovery phase, was conducted to assess the reversibility of any observed effects. Necropsy was performed on Day 198 of the dosing phase for four animals/group and Day 365 of the recovery phase for the remaining eight animals/group.Results: No GBCA‐related adverse effects were observed in juvenile cynomolgus monkeys either at the end of the dosing or recovery periods. The no‐observed‐effect‐levels (NOEL) for gadobutrol and gadodiamide administration were 0.9 mmol/kg and, for gadobenate dimeglumine, 0.3 mmol/kg (due to a non‐adverse difference in learning during the recovery phase in the high dose group). The no‐observed‐adverse‐effect‐level (NOAEL) for all GBCAs was established as at least 0.9 mmol/kg.Conclusions: Gd levels observed in brain tissue of cynomolgus monkey after juvenile exposure to multiples of equivalent clinical doses of all GBCAs tested did not correlate with any adverse morphological or functional findings. This study showed no evidence that exposure to GBCA during development presents a potential risk for long‐term effects such as behavioral, neurological, or histopathological findings in the brain, and/or impaired learning or memory.
- Open Access
- 1 August 2020
- Published by Elsevier in Reproductive Toxicology
- Vol. 95, 29-36
Enhanced normograms and pregnancy outcome analysis in nonhuman primate developmental toxicity studies
- 1 August 2020
- Published by Elsevier in Reproductive Toxicology
- Vol. 95, 29-36
Open AccessEnhanced normograms and pregnancy outcome analysis in nonhuman primate developmental toxicity studies
- 17 October 2001
- Published by Wiley in American Journal of Primatology
- Vol. 55 (3) , 159-170
Maternal or fetal origin of rhesus monkey (Macaca mulatta) amniotic fluid leukocytes can be identified by polymerase chain reaction using the zinc finger Y gene
Leukocytes can be found in substantial numbers within the intrauterine tissues and amniotic fluid of women, and play a central role in the pathophysiology of infection‐related preterm labor by their production of proinflammatory mediators. It remains unclear whether these leukocytes represent a fetal immune response, a maternal response, or a combination of the two. The objective of this study was to develop a test in the rhesus monkey (Macaca mulatta) suitable for determining the percentage of male fetal cells present in a population of leukocytes recovered from blood or amniotic fluid. We found inadequate specificity for rhesus monkey cells using commercial human Y‐chromosome paint kits (fluorescence in situ hybridization (FISH)). Human‐specific primers for the repetitive Y chromosome DYZ‐1 locus employed in the polymerase chain reaction (PCR) produced an unacceptable percentage of false positives. However, we successfully developed a PCR‐based test using rhesus‐specific primers for the zinc finger Y (ZFY) locus. Densitometry of PCR products from known ratios of male and female adult peripheral leukocytes generated a linear standard curve which provided quantitative results and required only 400 cells per sample. The rhesus beta globin (RBG) gene served as an internal control. The PCR test correctly discriminated the sex of peripheral leukocytes in 20 adult males, 20 adult females, two male fetuses, and one female fetus. Serial samples of amniotic fluid from four chronically catheterized rhesus monkeys bearing male fetuses were used to confirm the utility of this assay for quantifying fetal cells in amniotic fluid. In conclusion, we have developed a PCR test which is suitable for distinguishing male from female cells in adult and fetal blood and in amniotic fluid, which lends itself to a variety of diagnostic and biologic applications in the rhesus monkey and potentially in other nonhuman primates. Am. J. Primatol. 55:159–170, 2001.
- 17 October 2001
- Published by Wiley in American Journal of Primatology
- Vol. 55 (3) , 159-170
Maternal or fetal origin of rhesus monkey (Macaca mulatta) amniotic fluid leukocytes can be identified by polymerase chain reaction using the zinc finger Y gene
Leukocytes can be found in substantial numbers within the intrauterine tissues and amniotic fluid of women, and play a central role in the pathophysiology of infection‐related preterm labor by their production of proinflammatory mediators. It remains unclear whether these leukocytes represent a fetal immune response, a maternal response, or a combination of the two. The objective of this study was to develop a test in the rhesus monkey (Macaca mulatta) suitable for determining the percentage of male fetal cells present in a population of leukocytes recovered from blood or amniotic fluid. We found inadequate specificity for rhesus monkey cells using commercial human Y‐chromosome paint kits (fluorescence in situ hybridization (FISH)). Human‐specific primers for the repetitive Y chromosome DYZ‐1 locus employed in the polymerase chain reaction (PCR) produced an unacceptable percentage of false positives. However, we successfully developed a PCR‐based test using rhesus‐specific primers for the zinc finger Y (ZFY) locus. Densitometry of PCR products from known ratios of male and female adult peripheral leukocytes generated a linear standard curve which provided quantitative results and required only 400 cells per sample. The rhesus beta globin (RBG) gene served as an internal control. The PCR test correctly discriminated the sex of peripheral leukocytes in 20 adult males, 20 adult females, two male fetuses, and one female fetus. Serial samples of amniotic fluid from four chronically catheterized rhesus monkeys bearing male fetuses were used to confirm the utility of this assay for quantifying fetal cells in amniotic fluid. In conclusion, we have developed a PCR test which is suitable for distinguishing male from female cells in adult and fetal blood and in amniotic fluid, which lends itself to a variety of diagnostic and biologic applications in the rhesus monkey and potentially in other nonhuman primates. Am. J. Primatol. 55:159–170, 2001.
- 1 April 1999
- Published by Elsevier in The Lancet
- Vol. 353 (9160) , 1240
Non-random chromosome positioning in human sperm and sex chromosome anomalies following intracytoplasmic sperm injection
- 1 April 1999
- Published by Elsevier in The Lancet
- Vol. 353 (9160) , 1240
Non-random chromosome positioning in human sperm and sex chromosome anomalies following intracytoplasmic sperm injection